The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation ...
BaseLaunch, a platform partnering with scientists and entrepreneurs to launch, fund, and build early biotech ventures, ...
Our Bureau, Bengaluru Friday, February 13, 2026, 12:20 Hrs [IST] ...
CNW/ - This World Cancer Day, Pfizer Canada ULC ("Pfizer"), in partnership with leading oncology patient organizations, is ...
The U.S. FDA has accepted and granted Priority Review for Pfizer’s supplemental Biologics License Application (sBLA) for ...
PFE, has entered a global licensing agreement with Novavax to use Matrix-M adjuvant technology in the development of up to two infectious disease vaccines. The deal grants Pfizer non-exclusive ...
FDA priority review seeks marstacimab label expansion to ≥6 years with inhibitors and ages 6–11 without inhibitors, addressing populations with limited efficacy from factor replacement and high unmet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results